Our use of primary cell systems allows us to provide our clients with more predictable and clinically-relevant assays.
Our new video highlights the drug development platform, cellPrism®,
which has been useful at predicting program
challenges like cytokine storm and neutropenia.
Our use of primary cell systems allows us to provide our clients with more predictable and clinically-relevant assays.
Our extensive knowledge, and use of primary cell products allows us to confidently provide high quality primary cells from bone marrow, peripheral blood and cord blood.
